Bank of New York Mellon’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.55M Buy
89,138
+7,085
+9% +$225K ﹤0.01% 2811
2026
Q1
$2.58M Buy
82,053
+18,900
+30% +$595K ﹤0.01% 2684
2025
Q4
$1.86M Buy
63,153
+20,239
+47% +$562K ﹤0.01% 2884
2025
Q3
$1.08M Buy
42,914
+16,994
+66% +$414K ﹤0.01% 3174
2025
Q2
$622K Sell
25,920
-4,829
-16% -$112K ﹤0.01% 3389
2025
Q1
$704K Sell
30,749
-352,808
-92% -$8.51M ﹤0.01% 3261
2024
Q4
$9.71M Sell
383,557
-227,314
-37% -$5.76M ﹤0.01% 1940
2024
Q3
$15.2M Sell
610,871
-303,929
-33% -$9M ﹤0.01% 1718
2024
Q2
$27.1M Sell
914,800
-18,372
-2% -$510K 0.01% 1402
2024
Q1
$28.1M Buy
933,172
+77,559
+9% +$2.15M 0.01% 1383
2023
Q4
$24.5M Sell
855,613
-5,450
-0.6% -$160K 0.01% 1491
2023
Q3
$31.9M Sell
861,063
-12,315
-1% -$470K 0.01% 1269
2023
Q2
$34.1M Sell
873,378
-70,777
-7% -$2.77M 0.01% 1239
2023
Q1
$34.5M Sell
944,155
-17,501
-2% -$552K 0.01% 1229
2022
Q4
$29.6M Buy
+961,656
New +$29.9M 0.01% 1318

Other funds holding RTO

Bank of New York Mellon's RTO Position: Q2 2026 in Review

Bank of New York Mellon increased its Rentokil (RTO) stake by 8.6% in Q2 2026, buying an estimated $225K and bringing the position to 89,138 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2811.

Bank of New York Mellon first reported a position in RTO in Q4 2022 and has held it in 15 quarters since. The position peaked at $34.5M in Q1 2023. 138 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Bank of New York Mellon held 89,138 shares of Rentokil worth $2.55M as of Q2 2026.
  • Bank of New York Mellon bought 7,085 Rentokil shares in Q2 2026, an estimated $225K.
  • Rentokil made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2811 holding.
  • Bank of New York Mellon first reported a position in Rentokil in Q4 2022 and has held it in 15 quarters since.
  • Bank of New York Mellon's Rentokil position peaked at $34.5M in Q1 2023.
  • 138 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.